Redx Pharma Plc (LON:REDX)

Redx Pharma Plc (LON:REDX)


Share Price
5.35 p
Change
0 (0.00 %)
Market Cap
£6.77 m
Proactive Investors - Run By Investors For Investors

Redx Pharma Plc RNS Release

Publication of Annual Report and Accounts


RNS Number : 7318L
Redx Pharma plc
28 December 2018
 

28 December 2018

 

REDX PHARMA PLC

("Redx" or "the Company")

 

Annual Report and Accounts

 

The Company announces that it will today be posting to shareholders the Annual Report and Accounts for the year ended 30 September 2018, together with the notice of the Annual General Meeting.  The Annual General Meeting will be held at 11am on 23 January 2019 at the offices of WG Partners, 85 Gresham Street, London EC2V 7NQ.

 

The Report and Accounts are also available on the Company's website, www.redxpharma.com.

 

For further information, please contact:

Redx Pharma Plc

T: +44 1625 469 920

Lisa Anson, Chief Executive Officer


Dominic Jackson, Chief Financial Officer




Cantor Fitzgerald Europe (Nominated Advisor & Joint Broker)

 T: +44 20 7894 7000

Phil Davies




WG Partners LLP (Joint Broker)

T: +44 20 3705 9330

Claes Spång/ Chris Lee/ David Wilson




FTI Consulting

T: +44 20 3727 1000

Simon Conway/Stephanie Cuthbert


 

About Redx Pharma Plc 

Redx is a UK based biotechnology company whose shares are traded on AIM (AIM:REDX). Redx's vision is to become a leading biotech focused on the development of novel precision medicines that have the potential to transform treatment in oncology and fibrotic diseases.

 

If you would like to sign up to regular alerts from Redx Pharma, please follow this link https://www.redxpharma.com/investors/email-alerts/


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ACSDMMZZMRDGRZM

Redx Pharma Plc Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use